Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-008861

Director sold 8,760 shares at $150.02 ($1,314,142)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SHERWIN STEPHEN A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-07 Sale : show line 1 in the form 10b5-1 −8,760 $150.02 $1,314,142 11,318 D
Open-market sales · 8,760 sh · avg $150.02 · $1,314,142
Loading xslF345X05/form4.xml…